HALO logo
halo search icon
REGENXBIO, Inc.

US$5.97

Price Change Indicator
0.31 (5.48%)
REGENXBIO, Inc.
RGNX · NAS

REGENXBIO, Inc.

Start Trading RGNX for Free

US$5.97

Price Arrow0.31 (5.48%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEngulfing BullishEngulfing Bullish (Realtime)HALO AllHALO Consensus ValueHammer BearishHammer Bearish (Realtime)+4
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

REGENXBIO, Inc. Overview

RGNX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About RGNX

icon
icon

Telephone

1.240.552.8181

icon

Address

9804 Medical Center Drive, Rockville, MD 20850

Description

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

RGNX Price Chart

Key Stats

Market Cap

US$292.61M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5.45 - 16.19

Trade Value (12mth)

US$2,082,272.00

1 week

-1.05%

1 month

-37.87%

YTD

-58.29%

1 year

-41.29%

All time high

85.10

Key Fundamentals

EPS 3 yr Growth

-42.10%

EBITDA Margin

-85.40%

Operating Cashflow

-$124m

Free Cash Flow Return

-36.80%

ROIC

-57.50%

Interest Coverage

-3.20

Quick Ratio

2.40

Other Data

Shares Outstanding (Fully Diluted)

52m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RGNX Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

RGNX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-6.02-4.59-3.76locklocklock
EPS (Fully Diluted)
 $locklocklocklock-6.02-4.59-3.76locklocklock
Growth
 %locklocklocklock7.323.918locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of REGENXBIO, Inc. (RGNX:NAS)?
Halo FAQ
The current share price of REGENXBIO, Inc. (RGNX:NAS) is USD$5.97.
What is the 52-week high share price for REGENXBIO, Inc. (RGNX:NAS)?
Halo FAQ
The 52-week high share price for REGENXBIO, Inc. (RGNX:NAS) is USD$16.19.
What is the 52-week low share price for REGENXBIO, Inc. (RGNX:NAS)?
Halo FAQ
The 52-week low share price for REGENXBIO, Inc. (RGNX:NAS) is USD$5.45.
What is the dividend yield for REGENXBIO, Inc. (RGNX:NAS)?
Halo FAQ
REGENXBIO, Inc. (RGNX:NAS) does not pay a dividend.
What was REGENXBIO, Inc. (RGNX:NAS) last dividend payment?
Halo FAQ
REGENXBIO, Inc. (RGNX:NAS) does not pay a dividend.
What is the franking level for REGENXBIO, Inc. (RGNX:NAS)?
Halo FAQ
REGENXBIO, Inc. (RGNX:NAS) has a franking level of 0.00%.
In which sector is REGENXBIO, Inc. (RGNX:NAS) classified?
Halo FAQ
REGENXBIO, Inc. (RGNX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial